ISOPP member expertise needed to serve on an ISOPP Task Force reviewing / endorsing the ADDIKD draft guideline. ISOPP has been invited by the NSW Cancer Institute to review/endorse the eviQ ‘Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD)’ draft guideline. Email services@isopp.orgby Tuesday, May 17, if you would like to serve on this time-limited opportunity.
Submitted by Lynne Nakashima, Chair, ISOPP Immunotherapy Task Force
The ISOPP Immunotherapy Task Force has been hard at work since the fall of 2020, developing resources to assist oncology pharmacy practitioners in managing the care of patients on immunotherapy.
ISOPP Members, the ISOPP quarterly Newsletter was distributed to your inbox on Friday April 8th. Read about updates and other important news from ISOPP!
ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions:
The position paper developed by the Immunotherapy Task Force has been published online ahead of print by JOPP. View the paper on the ISOPP website here.